HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mihir Kakara Selected Research

Multiple Sclerosis

1/2023Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
12/2022Progressive multifocal leukoencephalopathy in anti-CD20 and other monoclonal antibody (mAb) therapies used in multiple sclerosis: A review.
12/2022Updates on efficacy and safety outcomes of new and emerging disease modifying therapies and stem cell therapy for Multiple Sclerosis: A review.
3/2022The elimination of circulating Epstein-Barr virus infected B cells underlies anti-CD20 monoclonal antibody activity in multiple sclerosis: A hypothesis.
11/2021Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mihir Kakara Research Topics

Disease

5Multiple Sclerosis
01/2023 - 11/2021
2Infections
12/2022 - 12/2021
1Leukemia
12/2022
1Progressive Multifocal Leukoencephalopathy
12/2022
1Lymphoma (Lymphomas)
12/2022
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2022
1Inflammation (Inflammations)
03/2022
1Transverse Myelitis (Necrotizing Myelitis)
12/2021
1Neuromyelitis Optica (Devic's Disease)
12/2021
1Optic Neuritis (Retrobulbar Neuritis)
12/2021
1Brain Diseases (Brain Disorder)
12/2021
1Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
12/2021
1Acute Hemorrhagic Leukoencephalitis (Hurst Syndrome)
12/2021
1Septic Shock (Toxic Shock Syndrome)
12/2021
1Myelitis
12/2021
1COVID-19
11/2021
1Ischemia
01/2016

Drug/Important Bio-Agent (IBA)

2Monoclonal AntibodiesIBA
12/2022 - 03/2022
1efalizumab (Raptiva)FDA Link
12/2022
1ofatumumabFDA Link
12/2022
1Rituximab (Mabthera)FDA Link
12/2022
1Natalizumab (Tysabri)FDA Link
12/2022
1Myelin-Oligodendrocyte GlycoproteinIBA
12/2021
1Messenger RNA (mRNA)IBA
11/2021
12019-nCoV Vaccine mRNA-1273IBA
11/2021
1BNT162 VaccineIBA
11/2021
1AntigensIBA
11/2021

Therapy/Procedure

6Therapeutics
01/2023 - 01/2016
1Artificial Respiration (Mechanical Ventilation)
12/2021